BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8878586)

  • 1. Single-dose and steady-state pharmacokinetics of hypericin and pseudohypericin.
    Kerb R; Brockmöller J; Staffeldt B; Ploch M; Roots I
    Antimicrob Agents Chemother; 1996 Sep; 40(9):2087-93. PubMed ID: 8878586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of hypericin and pseudohypericin after oral intake of the hypericum perforatum extract LI 160 in healthy volunteers.
    Staffeldt B; Kerb R; Brockmöller J; Ploch M; Roots I
    J Geriatr Psychiatry Neurol; 1994 Oct; 7 Suppl 1():S47-53. PubMed ID: 7857509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of the bioavailability of hypericin, pseudohypericin, hyperforin and the flavonoids quercetin and isorhamnetin following single and multiple oral dosing of a hypericum extract containing tablet.
    Schulz HU; Schürer M; Bässler D; Weiser D
    Arzneimittelforschung; 2005; 55(1):15-22. PubMed ID: 15727160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of pharmacokinetic data of hypericin, pseudohypericin, hyperforin and the flavonoids quercetin and isorhamnetin revealed from single and multiple oral dose studies with a hypericum extract containing tablet in healthy male volunteers.
    Schulz HU; Schürer M; Bässler D; Weiser D
    Arzneimittelforschung; 2005; 55(10):561-8. PubMed ID: 16294501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypericin and pseudohypericin: pharmacokinetics and effects on photosensitivity in humans.
    Brockmöller J; Reum T; Bauer S; Kerb R; Hübner WD; Roots I
    Pharmacopsychiatry; 1997 Sep; 30 Suppl 2():94-101. PubMed ID: 9342768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypericin levels in human serum and interstitial skin blister fluid after oral single-dose and steady-state administration of Hypericum perforatum extract (St. John's wort).
    Schempp CM; Winghofer B; Langheinrich M; Schöpf E; Simon JC
    Skin Pharmacol Appl Skin Physiol; 1999; 12(5):299-304. PubMed ID: 10461100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of cytochrome P-450 inhibition by cimetidine and induction by carbamazepine on the kinetics of hypericin and pseudohypericin in healthy volunteers.
    Johne A; Perloff ES; Bauer S; Schmider J; Mai I; Brockmöller J; Roots I
    Eur J Clin Pharmacol; 2004 Nov; 60(9):617-22. PubMed ID: 15372129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral bioavailability of hyperforin from hypericum extracts in rats and human volunteers.
    Biber A; Fischer H; Römer A; Chatterjee SS
    Pharmacopsychiatry; 1998 Jun; 31 Suppl 1():36-43. PubMed ID: 9684946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-blind evaluation of the safety and pharmacokinetics of multiple oral once-daily 750-milligram and 1-gram doses of levofloxacin in healthy volunteers.
    Chien SC; Wong FA; Fowler CL; Callery-D'Amico SV; Williams RR; Nayak R; Chow AT
    Antimicrob Agents Chemother; 1998 Apr; 42(4):885-8. PubMed ID: 9559801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics, safety, and antiviral effects of hypericin, a derivative of St. John's wort plant, in patients with chronic hepatitis C virus infection.
    Jacobson JM; Feinman L; Liebes L; Ostrow N; Koslowski V; Tobia A; Cabana BE; Lee D; Spritzler J; Prince AM
    Antimicrob Agents Chemother; 2001 Feb; 45(2):517-24. PubMed ID: 11158749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral bioavailability of active principles from herbal products in humans. A study on Hypericum perforatum extracts using the soft gelatin capsule technology.
    Agrosi M; Mischiatti S; Harrasser PC; Savio D
    Phytomedicine; 2000 Dec; 7(6):455-62. PubMed ID: 11194173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma pharmacokinetics and cerebrospinal fluid penetration of hypericin in nonhuman primates.
    Fox E; Murphy RF; McCully CL; Adamson PC
    Cancer Chemother Pharmacol; 2001; 47(1):41-4. PubMed ID: 11221960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of St. John's wort supplementation on the pharmacokinetics of bupropion in healthy male Chinese volunteers.
    Lei HP; Yu XY; Xie HT; Li HH; Fan L; Dai LL; Chen Y; Zhou HH
    Xenobiotica; 2010 Apr; 40(4):275-81. PubMed ID: 20102294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic interaction of digoxin with an herbal extract from St John's wort (Hypericum perforatum).
    Johne A; Brockmöller J; Bauer S; Maurer A; Langheinrich M; Roots I
    Clin Pharmacol Ther; 1999 Oct; 66(4):338-45. PubMed ID: 10546917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.
    Keam SJ; Keating GM
    Treat Respir Med; 2004; 3(4):247-68. PubMed ID: 15350163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of hyperforin, hypericin, and pseudohypericin in human plasma using high-performance liquid chromatography analysis with fluorescence and ultraviolet detection.
    Bauer S; Störmer E; Graubaum HJ; Roots I
    J Chromatogr B Biomed Sci Appl; 2001 Dec; 765(1):29-35. PubMed ID: 11817306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of St. John's wort (Hypericum perforatum) on tacrolimus pharmacokinetics in healthy volunteers.
    Hebert MF; Park JM; Chen YL; Akhtar S; Larson AM
    J Clin Pharmacol; 2004 Jan; 44(1):89-94. PubMed ID: 14681346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of oral administration ofHypericum perforatum extract (St. John's Wort) on skin erythema and pigmentation induced by UVB, UVA, visible light and solar simulated radiation.
    Schempp CM; Winghofer B; Müller K; Schulte-Mönting J; Mannel M; Schöpf E; Simon JC
    Phytother Res; 2003 Feb; 17(2):141-6. PubMed ID: 12601676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of the anti-human immunodeficiency virus agent 1-(beta-D-dioxolane)thymine in rhesus monkeys.
    Asif G; Hurwitz SJ; Obikhod A; Delinsky D; Narayanasamy J; Chu CK; McClure HM; Schinazi RF
    Antimicrob Agents Chemother; 2007 Jul; 51(7):2424-9. PubMed ID: 17485498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of 2',3'-dideoxyinosine (BMY-40900), a new anti-human immunodeficiency virus agent, after administration of single intravenous doses to beagle dogs.
    Kaul S; Knupp CA; Dandekar KA; Pittman KA; Barbhaiya RH
    Antimicrob Agents Chemother; 1991 Apr; 35(4):610-4. PubMed ID: 1906259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.